We Never Know
No Slack
How do you know which one to believe and accept when they have opposing data?
The FDA approves remdesivir for covid treatment
Remdesivir | COVID-19 Treatment Guidelines
The WHO recommends against using it.
WHO recommends against the use of remdesivir in COVID-19 patients
WHO announces three new drugs for latest COVID-19 'Solidarity' trials.
The therapies — artesunate, imatinib and infliximab — will be tested on hospitalized COVID-19 patients in 52 countries under the Solidarity PLUS programme.
Four drugs were evaluated under the initial Solidarity Trial last year, which showed that remdesivir, hydroxychloroquine, lopinavir and interferon had little or no effect on hospitalized patients with COVID-19.
WHO announces three new drugs for latest COVID-19 'Solidarity' trials
The FDA approves remdesivir for covid treatment
Remdesivir | COVID-19 Treatment Guidelines
The WHO recommends against using it.
WHO recommends against the use of remdesivir in COVID-19 patients
WHO announces three new drugs for latest COVID-19 'Solidarity' trials.
The therapies — artesunate, imatinib and infliximab — will be tested on hospitalized COVID-19 patients in 52 countries under the Solidarity PLUS programme.
Four drugs were evaluated under the initial Solidarity Trial last year, which showed that remdesivir, hydroxychloroquine, lopinavir and interferon had little or no effect on hospitalized patients with COVID-19.
WHO announces three new drugs for latest COVID-19 'Solidarity' trials